Galderma Slumps After FDA Turns Down Botox Rival Relfydess
Galderma’s shares slumped the most in more than a year after US regulators turned down the Swiss dermatology firm’s rival Botox treatment Relfydess. Source link
Galderma’s shares slumped the most in more than a year after US regulators turned down the Swiss dermatology firm’s rival Botox treatment Relfydess. Source link
The model and muse explained her supermodel origin story and her plans for her next act onstage at The Business of Beauty Global Forum. Source link
The Estée Lauder Companies, which is behind global beauty brands including Bobbi Brown Cosmetics, Clinique, Jo Malone London, La Mer and Tom Ford Beauty, has new leadership driving strategic change…
Lululemon Athletica is appointing an executive with significant branding and marketing experience to its board as the athletic apparel maker’s founder presses management to revive its brand, sources told Reuters.…